Role of nonneutralizing antibodies in vaccines and/or HIV infected individuals.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Opinion in HIV and AIDS

• Publication date

  2017-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/COH.0000000000000357PMID 28230656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection.

  2016cited by this paper
• Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control

  2016cited by this paper
• Utility of a Dengue-Derived Monoclonal Antibody to Enhance Zika Infection In Vitro

  2016cited by this paper
• Expression Profile of Human Fc Receptors in Mucosal Tissue: Implications for Antibody-Dependent Cellular Effector Functions Targeting HIV-1 Transmission

  2016cited by this paper
• Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16

  2016cited by this paper
• Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.

  2016cited by this paper
• NK Cells in HIV Disease

  2016cited by this paper
• Fc Receptor-Mediated Phagocytosis in Tissues as a Potent Mechanism for Preventive and Therapeutic HIV Vaccine Strategies

  2016cited by this paper
• Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection

  2016cited by this paper
• HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1

  2016cited by this paper
• Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

  2016cited by this paper
• Molecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240

  2016cited by this paper
• Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus

  2016cited by this paper
• Modulating Antibody Functionality in Infectious Disease and Vaccination.

  2016cited by this paper
• Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in newborn macaques

  2016cited by this paper
• Relationship between Vaccine-Induced Antibody Capture of Infectious Virus and Infection Outcomes following Repeated Low-Dose Rectal Challenges with Simian Immunodeficiency Virus SIVmac251

  2016cited by this paper
• Zika Virus.

  2016cited by this paper
• Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge

  2015cited by this paper
• Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1

  2015influential reference
• Role of HIV-1 Envelope Glycoproteins Conformation and Accessory Proteins on ADCC Responses.

  2015cited by this paper
• Letter to the Editor on: The RV144 vaccine regimen was not associated with enhancement of infection

  2015cited by this paper
• New insights into the immunopathology and control of dengue virus infection

  2015cited by this paper
• Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques

  2015cited by this paper
• Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection.

  2015cited by this paper
• Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys

  2015cited by this paper
• Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection.

  2015cited by this paper
• A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus

  2014cited by this paper
• Which Antibody Functions are Important for an HIV Vaccine?

  2014cited by this paper
• Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines

  2014cited by this paper
• Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity

  2014cited by this paper
• Live Simian Immunodeficiency Virus Vaccine Correlate of Protection: Immune Complex–Inhibitory Fc Receptor Interactions That Reduce Target Cell Availability

  2014cited by this paper
• An H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in Humans

  2014cited by this paper
• Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques

  2013influential reference
• Therapeutic Efficacy of Potent Neutralizing HIV-1-Specific Monoclonal Antibodies in SHIV-Infected Rhesus Monkeys

  2013cited by this paper
• Differential Binding of IgG and IgA to Mucus of the Female Reproductive Tract

  2013cited by this paper
• The Neonatal Fc Receptor (FcRn) Enhances Human Immunodeficiency Virus Type 1 (HIV-1) Transcytosis across Epithelial Cells

  2013cited by this paper
• Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys.

  2013cited by this paper
• Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of Macaques

  2013cited by this paper
• Enhanced Phagocytic Activity of HIV-Specific Antibodies Correlates with Natural Production of Immunoglobulins with Skewed Affinity for FcγR2a and FcγR2b

  2013cited by this paper
• Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission

  2013cited by this paper
• Specific antibody‐dependent cellular cytotoxicity responses associated with slow progression of HIV infection

  2013cited by this paper
• Neutralizing IgG at the Portal of Infection Mediates Protection against Vaginal Simian/Human Immunodeficiency Virus Challenge

  2013cited by this paper
• Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment

  2013cited by this paper
• Immune-correlates analysis of an HIV-1 vaccine efficacy trial.

  2012cited by this paper
• Neutralizing antibodies inhibit HIV-1 transfer from primary dendritic cells to autologous CD4 T lymphocytes.

  2012cited by this paper
• Animal Models of Dengue Virus Infection

  2012cited by this paper
• Activation of NK Cells by ADCC Responses During Early HIV Infection

  2011cited by this paper
• An Anti-HIV-1 V3 Loop Antibody Fully Protects Cross-Clade and Elicits T-Cell Immunity in Macaques Mucosally Challenged with an R5 Clade C SHIV

  2011cited by this paper
• A Crucial Role for Infected-Cell/Antibody Immune Complexes in the Enhancement of Endogenous Antiviral Immunity by Short Passive Immunotherapy

  2010cited by this paper
• Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response.

  2010cited by this paper
• Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques

  2010cited by this paper
• Antibody‐mediated modulation of immune responses

  2010cited by this paper
• Utilization of Immunoglobulin G Fc Receptors by Human Immunodeficiency Virus Type 1: a Specific Role for Antibodies against the Membrane-Proximal External Region of gp41

  2009cited by this paper
• A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection

  2008cited by this paper
• Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1

  2007cited by this paper
• Fc receptor but not complement binding is important in antibody protection against HIV

  2007cited by this paper
• Nonneutralizing Antibodies Are Able To Inhibit Human Immunodeficiency Virus Type 1 Replication in Macrophages and Immature Dendritic Cells

  2006cited by this paper
• Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

  2006cited by this paper
• The Animal Models for Dengue Virus Infection

  2004cited by this paper
• Immunization with Recombinant Canarypox Vectors Expressing Membrane-Anchored Glycoprotein 120 Followed by Glycoprotein 160 Boosting Fails to Generate Antibodies That Neutralize R5 Primary Isolates of Human Immunodeficiency Virus Type 1

  2000cited by this paper
• Fcγ Receptor–mediated Induction of Dendritic Cell Maturation and Major Histocompatibility Complex Class I–restricted Antigen Presentation after Immune Complex Internalization

  1999cited by this paper
• HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression.

  1996cited by this paper
• Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials.

  1993cited by this paper
• Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

  1977cited by this paper
• Antibody-enhanced dengue virus infection in primate leukocytes

  1977cited by this paper

• Phage-specific immunity impairs efficacy of bacteriophage targeting Vancomycin Resistant Enterococcus in a murine model

  2024cites this paper
• Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine

  2024cites this paper
• Phage-specific immune responses impair efficacy of phage therapy targeting VRE in a murine model

  2023cites this paper
• Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies Are Isotype-Dependent

  2022cites this paper
• Non‐neutralizing antibodies protect against chronic LCMV infection by promoting infection of inflammatory monocytes in mice

  2021cites this paper
• The alpha helix 1 from the first conserved region of HIV1 gp120 is reconstructed in the short NQ21 peptide.

  2018cites this paper
• Non-Neutralizing Antibodies Directed against HIV and Their Functions

  2017cites this paper
• Lessons learned from human HIV vaccine trials

  2017cites this paper